fda and compounded glp 1 GLP-1 Safety Check Today, the FDA is announcing

Phase 2 trials (Jastreboff et al., NEJM, 2023) have shown it to be highly effective for weight reduction in adults with obesity

L.BatemanR.BlennowK.RoweC

In a world where health supplements are plentiful, glutathione stands out for its numerous benefits

Maintenance doses are given less often than initial doses

To ensure the best outcomes, it is recommended to consult with a healthcare provider for guidance on transitioning off Semaglutide GLP-1 and creating a plan that supports lifelong weight management

Betul Ibis and colleagues, used the TriNetX database to compare 217,302 diabetes patients on GLP-1 medications with 217,302 matched patients on DPP-4 inhibitors. Patients on GLP-1s had a significantly lower risk of developing rheumatoid arthritis (HR = 0.87, p = 0.026), gout, and osteoarthritis within one year